人工心臓弁の世界市場ー産業および機会分析ー2016-2026:機械式心臓弁、生体/組織心臓弁、経カテーテル心臓弁

Future Market Insightsが発行した調査報告書(FMI612046)
◆英語タイトル:Prosthetic Heart Valve Market: Global Industry Analysis & Opportunity Assessment, 2016-2026
◆商品コード:FMI612046
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2016年10月20日
◆ページ数:134
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,130,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Mechanical heart valve is an artificial heart valve implanted in patients suffering from indicated diseases such as aortic stenosis or mitral regurgitation. Tissue heart valves are the biological valves harvested from cow heart sac (bovine) or porcine (pig) heart valves mounted on a stent or used without a stent to replace a dysfunctional heart valve. The global prosthetic heart valve market revenue is projected to register a CAGR of 12.0% during the forecast period (2016-2026) and reach a market valuation of US$ 19.60 Bn by the end of 2026.
Rising prevalence of valvular heart disease (VHD) expected to augment market growth

Increasing occurrences of valvular heart disease (VHD) is one of the primary drivers impacting the global prosthetic heart valve market. Other factors fuelling the demand for prosthetic heart valves include regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures. Prosthetic heart values are an effective alternative to cumbersome open heart surgery, and this is one of the main reasons for a global preference for prosthetic heart valves.

However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.

Market segmentation

By Product Type

By End User

By Region

Mechanical Heart Valves

Mechanical Aortic Valve

Mechanical Mitral Valve

Biological/Tissue Heart Valves

Tissue Aortic Valve

Tissue Mitral Valve

Transcatheter Heart Valves

Transcatheter Aortic Valve

Transcatheter Mitral Valve

Hospitals

Ambulatory Surgery Centres

North America

Latin America Excluding Brazil

Brazil

Western Europe

Eastern Europe

Asia Pacific Excluding Japan (APEJ)

Middle East & Africa (MEA)

Tissue Heart Valves product type segment expected to dominate the global prosthetic heart valve market in terms of value

The Tissue Heart Valves segment is anticipated to register a CAGR of 12.2% during the forecast period. The Transcatheter Heart Valves segment accounted for 27.2% value share of the global prosthetic heart valve market in 2015 and is estimated to account for over 31.0% revenue share of the global prosthetic heart valve market by the end of 2026.

Hospitals end user segment likely to project increased revenue growth during the forecast period

The Hospitals segment is anticipated to be valued at US$ 4,717.2 Mn by the end of 2016 and register a CAGR of 12.2% over the forecast period to reach a market valuation of US$ 14.9 Bn by the end of 2026. The Hospitals segment is projected to remain dominant in the global prosthetic heart valve market in terms of value over the forecast period, attributed to a large number of cardiac patients opting for hospitals to undergo treatment.

North America, Western Europe, and APEJ expected to be the fastest growing regional markets throughout the forecast period

North America and Western Europe accounted for over half the revenue share of the global prosthetic heart valve market in 2015. The North America prosthetic heart valve market accounted for a market share of 41.0% in 2015 and is expected to retain its dominance in terms of revenue in the global prosthetic heart valve market throughout the forecast period. Increased THV procedures coupled with rising adoption of technological advancements in an effort to reduce treatment duration for high conventional surgical risk patients is expected to result in significant growth of the global prosthetic heart valve market in North America. The Western Europe prosthetic heart valve market is expected to account for the second largest market value share owing to product maturity and increased awareness levels among the population in the region.

prosthetic heart valve market

Leading market players are concentrating on providing differentiated treatment options to patients to retain market share

Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc. are some of the leading players operating in the global prosthetic heart valve market. Top companies are focussing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.

【レポートの目次】

Table Of Content
1. Executive Summary

2. Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

2.3. Parent / Associated Market Overview

3. Global Prosthetic Heart Valve Market Analysis Scenario

3.1. Pricing Analysis

3.1.1. Pricing Assumptions

3.1.2. Price Projections Per Region

3.2. Market Overview

3.2.1. Value Chain

3.2.2. Profitability Margins

4. Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5.Forecast Factors – Relevance and Impact

4.6.Regulations (U.S., Europe & Japan)

5. Global Prosthetic Heart Valve Market Analysis and Forecasts, By Product Type

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Product Type Type

5.3. Y-o-Y Growth Projections By Product Type Type

5.4. Market Value Forecast By Product Type , 2014–2026

5.4.1. Mechanical Heart Valves

5.4.1.1. Mechanical Aortic Valve

5.4.1.2. Mechanical Mitral Valve

5.4.2. Biological/Tissue Heart Valves

5.4.2.1. Tissue Aortic Valve

5.4.2.2. Tissue Mitral Valve

5.4.3. Transcatheter Heart Valves

5.4.3.1. Transcatheter Aortic Valve

5.4.3.2. Transcatheter Mitral Valve

5.5. Prominent Trends

5.6. Market Attractiveness By Product Type

6. Global Prosthetic Heart Valve Market Analysis and Forecasts, By End User

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Product Type Type

6.3. Y-o-Y Growth Projections By Product Type Type

6.4. Market Value Forecast By End User , 2014–2026

6.4.1. Hospitals

6.4.2. Ambulatory Surgery Centres

6.5. Prominent Trends

6.6. Market Attractiveness By End User

7. Global Prosthetic Heart Valve Market Analysis and Forecasts, By Region

7.1. Basis Point Share (BPS) Analysis By Country

7.2. Y-o-Y Growth Projections By Country

7.3. Market Value Forecast By Region

7.3.1. North America

7.3.2. Latin America Excluding Brazil

7.3.3. Brazil

7.3.4. Western Europe

7.3.5. Eastern Europe

7.3.6. Asia Pacific Excl. Japan (APEJ)

7.3.7. Japan

7.3.8. MEA

7.4. Market Attractiveness By Country/Region

7.5. Impact Analysis of Market Dynamics, By Region/Country

8. North America Prosthetic Heart Valve Market Analysis and Forecast

8.1. Introduction

8.1.1. Basis Point Share (BPS) Analysis By Country

8.1.2. Y-o-Y Growth Projections By Country

8.2. Market Value Forecast By Product Type , 2014–2026

8.2.1. Mechanical Heart Valves

8.2.1.1. Mechanical Aortic Valve

8.2.1.2. Mechanical Mitral Valve

8.2.2. Biological/Tissue Heart Valves

8.2.2.1. Tissue Aortic Valve

8.2.2.2. Tissue Mitral Valve

8.2.3. Transcatheter Heart Valves

8.2.3.1. Transcatheter Aortic Valve

8.2.3.2. Transcatheter Mitral Valve

8.3. Market Value Forecast By End User , 2014–2026

8.3.1. Hospitals

8.3.2. Ambulatory Surgery Centres

8.4. Market Value Forecast By Country , 2014–2026

8.4.1. U.S.

8.4.2. Canada

8.5. Market Attractiveness Analysis

8.5.1. By Product Type

8.5.2. By End User

8.5.3. By Country

9. Latin America Excluding Brazil Prosthetic Heart Valve Market Analysis and Forecast

9.1. Introduction

9.1.1. Basis Point Share (BPS) Analysis By Country

9.1.2. Y-o-Y Growth Projections By Country

9.2. Market Value Forecast By Product Type , 2014–2026

9.2.1. Mechanical Heart Valves

9.2.1.1. Mechanical Aortic Valve

9.2.1.2. Mechanical Mitral Valve

9.2.2. Biological/Tissue Heart Valves

9.2.2.1. Tissue Aortic Valve

9.2.2.2. Tissue Mitral Valve

9.2.3. Transcatheter Heart Valves

9.2.3.1. Transcatheter Aortic Valve

9.2.3.2. Transcatheter Mitral Valve

9.3. Market Value Forecast By End User , 2014–2026

9.3.1. Hospitals

9.3.2. Ambulatory Surgery Centres

9.4. Market Value Forecast By Country , 2014–2026

9.4.1. Mexico

9.4.2. Argentina

9.4.3. Rest Of Latin America Excluding Brazil

9.5. Market Attractiveness Analysis

9.5.1. By Product Type

9.5.2. By End User

9.5.3. By Country

10. Brazil Prosthetic Heart Valve Market Analysis and Forecast

10.1.Introduction

10.2.Market Value Forecast By Product Type , 2014–2026

10.2.1. Mechanical Heart Valves

10.2.1.1. Mechanical Aortic Valve

10.2.1.2. Mechanical Mitral Valve

10.2.2. Biological/Tissue Heart Valves

10.2.2.1. Tissue Aortic Valve

10.2.2.2. Tissue Mitral Valve

10.2.3. Transcatheter Heart Valves

10.2.3.1. Transcatheter Aortic Valve

10.2.3.2. Transcatheter Mitral Valve

10.3.Market Value Forecast By End User , 2014–2026

10.3.1. Hospitals

10.3.2. Ambulatory Surgery Centres

10.4.Market Attractiveness Analysis

10.4.1. By Product Type

10.4.2. By End User

11. Western Europe Prosthetic Heart Valve Market Analysis and Forecast

11.1.Introduction

11.1.1. Basis Point Share (BPS) Analysis By Country

11.1.2. Y-o-Y Growth Projections By Country

11.2.Market Value Forecast By Product Type , 2014–2026

11.2.1. Mechanical Heart Valves

11.2.1.1. Mechanical Aortic Valve

11.2.1.2. Mechanical Mitral Valve

11.2.2. Biological/Tissue Heart Valves

11.2.2.1. Tissue Aortic Valve

11.2.2.2. Tissue Mitral Valve

11.2.3. Transcatheter Heart Valves

11.2.3.1. Transcatheter Aortic Valve

11.2.3.2. Transcatheter Mitral Valve

11.3.Market Value Forecast By End User , 2014–2026

11.3.1. Hospitals

11.3.2. Ambulatory Surgery Centres

11.4.Market Value Forecast By Country , 2014–2026

11.4.1. Germany

11.4.2. UK

11.4.3. France

11.4.4. Italy

11.4.5. Spain

11.4.6. Rest Of Western Europe

11.5.Market Attractiveness Analysis

11.5.1. By Product Type

11.5.2. By End User

11.5.3. By Country



【レポートのキーワード】

人工心臓弁、機械式心臓弁、生体/組織心臓弁、経カテーテル心臓弁

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 人工心臓弁の世界市場ー産業および機会分析ー2016-2026:機械式心臓弁、生体/組織心臓弁、経カテーテル心臓弁(Prosthetic Heart Valve Market: Global Industry Analysis & Opportunity Assessment, 2016-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆